Perrigo | PRGO - Selling And Administration Expenses



Perrigo reported $273.1M in Selling and Administration Expenses for its fiscal quarter ending in June of 2025.


Selling And Administration Expenses Change Date
AbbVie USD 3.25B 40M Jun/2025
Abbott USD 3.09B 39M Jun/2025
Bayer EUR 3.55B 162M Jun/2025
Bristol-Myers Squibb USD 1.71B 129M Jun/2025
Corcept Therapeutics USD 103.85M 13.19M Jun/2025
Dr.Reddys Laboratories INR 25.65B 10.39B Jun/2025
Eli Lilly USD 2.75B 390.8M Jun/2025
J&J USD 5.89B 777M Jun/2025
Merck USD 2.63B 104M Jun/2025
Nestle CHF 12.73B 181M Jun/2025
Pacira USD 77.19M 9.58M Jun/2025
Perrigo USD 273.1M 8.1M Jun/2025
Pfizer USD 3.42B 406M Jun/2025
Prestige Brands USD 28.46M 35.6M Jun/2025
Sanofi EUR 2.63B 408M Jun/2025
Supernus Pharmaceuticals USD 62.22M 27.72M Jun/2025
Teva Pharmaceutical Industries USD 959M 40M Jun/2025
Xeris Pharmaceuticals USD 44.39M 35.89M Jun/2025
Zoetis USD 617M 54M Jun/2025